TIOCETAM
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22
Solution for injection 5 ml №10 or 10 ml №10.
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22
-
Treatment of ischemic stroke and its consequences, such as speech disorders, mental and somatic illnesses, decreased activity, emotional disorders; treatment (in the rehabilitation period) of the vascular, toxic and traumatic encephalopathy; treatment of alcohol withdrawal syndrome, diabetic encephalopathy; hypersensitivity to tiazotic acid and/or piracetam; end-stage of renal disease; Huntington's disease; hemorrhagic stroke.
-
1 ml of the solution contains 25 mg of morpholine salt of tiazotic acid on 100% substance basis, which is equivalent to 16.6 mg of the tiazotic acid, 100 mg of piracetam.
